N6-methyladenosine regulates glycolysis of cancer cells through PDK4

Studies on biological functions of N-6-methyladenosine (m(6)A) modification in mRNA have sprung up in recent years. We find m(6)A can positively regulate the glycolysis of cancer cells. Specifically, m(6)A-sequencing and functional studies confirm that pyruvate dehydrogenase kinase 4 (PDK4) is involved in m(6)A regulated glycolysis and ATP generation. The m(6)A modified 5UTR of PDK4 positively regulates its translation elongation and mRNA stability via binding with YTHDF1/eEF-2 complex and IGF2BP3, respectively. Targeted specific demethylation of PDK4 m(6)A by dm(6)ACRISPR system can significantly decrease the expression of PDK4 and glycolysis of cancer cells. Further, TATA-binding protein (TBP) can transcriptionally increase the expression of Mettl3 in cervical cancer cells via binding to its promoter. In vivo and clinical data confirm the positive roles of m(6)A/PDK4 in tumor growth and progression of cervical and liver cancer. Our study reveals that m(6)A regulates glycolysis of cancer cells through PDK4. p id=Par ysregulation of N6-Methyladenosine (m(6)A) is associated with cancer progression. Here, authors show that m(6)A methylation of pyruvate dehydrogenase kinase 4 (PDK4) positively regulates its mRNA stability and translation, and consequently affects glycolysis in cancer cells